Phase II clinical trial of weekly administration of VP-16-213 in small cell bronchogenic carcinoma

MeSH terms

• Carcinoma, Bronchogenic / drug therapy*
• Carcinoma, Small Cell / drug therapy*
• Drug Administration Schedule
• Drug Evaluation
• Etoposide / administration & dosage*
• Etoposide / adverse effects
• Etoposide / therapeutic use
• Humans
• Leukopenia / chemically induced
• Lung Neoplasms / drug therapy*
• Podophyllotoxin / analogs & derivatives*
• Remission, Spontaneous
• Time Factors